Article Details
Retrieved on: 2021-01-19 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(KOSDAQ 095700), a South Korea-based Biotechnology company. Under the terms of the agreement, Turret Capital has obtained global rights for ...
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here